Drug

Who makes lifitegrast?

3 companies list lifitegrast as a human prescription drug, including under the names Xiidra. Forms: for solution; solution/ drops. Routes: ophthalmic.

Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology

Companies listing lifitegrast

CompanyFormsApplicationNDCsRegistered sites
Novartis Pharmaceuticals CorporationSwitzerlandsolution/ dropsNDANDA208073120
Aurobindo Pharma LimitedIndiafor solutionANDAANDA21506316
Bausch & Lomb Ireland LimitedUnited Statessolution/ dropsNDANDA20807314

Bulk ingredient listings

Orange Book patents

9 unexpired patents list lifitegrast as the active ingredient, expiring between Apr 2029 and Dec 2033. Application holder: BAUSCH AND LOMB INC.

Enquiry

Common questions

Who makes lifitegrast?
3 companies list lifitegrast as a human prescription drug in the openFDA NDC Directory, led by Novartis Pharmaceuticals Corporation, Aurobindo Pharma Limited, Bausch & Lomb Ireland Limited. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
Is there a generic Xiidra?
1 company lists lifitegrast under an abbreviated new drug application (ANDA), the application type used for generics, and 2 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.
Who supplies lifitegrast active ingredient?
12 companies list lifitegrast as a bulk ingredient, including Alivus Life Sciences Limited, Amino Chemicals Ltd., Aurobindo Pharma Limited, Cambrex Charles City, Inc..